CXCL12 and cancer: AMD3100 was able to return adhesion to baseline values at both flow rates, showing that the enhanced adhesion selectivity of circulating cancer cells is due to CXCL12 signaling through CXCR4 on the vascular endothelium (Figure 6A, B).